Selected research
Industry Growth & Trends
Global Parenteral Drugs Packaging Industry Growth and Trends Forecast to 2032
Market perspective
The global Parenteral Drugs Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Parenteral Drugs Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Parenteral Drugs Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Parenteral Drugs Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Parenteral Drugs Packaging include Ypsomed Holding AG, Gerresheimer AG, SiO2 Medical Products, Schott AG, Ompi Stevanato Group, Becton Dickinson and Company, MeadWestvaco Corporation, Unilife Corporation Inc and West Pharmaceutical Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Parenteral Drugs Packaging market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Parenteral Drugs Packaging market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Parenteral Drugs Packaging market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Parenteral Drugs Packaging.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Parenteral Drugs Packaging market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Parenteral Drugs Packaging Market by Company
Ypsomed Holding AG
Gerresheimer AG
SiO2 Medical Products
Schott AG
Ompi Stevanato Group
Becton Dickinson and Company
MeadWestvaco Corporation
Unilife Corporation Inc
West Pharmaceutical Services
Terumo Corporation
Berry Plastics Corporation
Owens-Illinois
RPC Group
Graphic Packaging Group
Parenteral Drugs Packaging Segment by Type
Polyvinyl Chloride (PVC)
Polyolefin
Parenteral Drugs Packaging Segment by Application
Large Volume Parenteral (LVP)
Small Volume Parenteral (SVP)
Parenteral Drugs Packaging Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs Packaging.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parenteral Drugs Packaging manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Parenteral Drugs Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyvinyl Chloride (PVC)
- Polyolefin
Applications
- Large Volume Parenteral (LVP)
- Small Volume Parenteral (SVP)
Companies covered
- Ypsomed Holding AG
- Gerresheimer AG
- SiO2 Medical Products
- Schott AG
- Ompi Stevanato Group
- Becton Dickinson and Company
- MeadWestvaco Corporation
- Unilife Corporation Inc
- West Pharmaceutical Services
- Terumo Corporation
- Berry Plastics Corporation
- Owens-Illinois
- RPC Group
- Graphic Packaging Group
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Parenteral Drugs Packaging Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Parenteral Drugs Packaging Sales Estimates and Forecasts (2021-2032)
- 1.3 Parenteral Drugs Packaging Market by Type
- 1.3.1 Polyvinyl Chloride (PVC)
- 1.3.2 Polyolefin
- 1.4 Global Parenteral Drugs Packaging Market Size by Type
- 1.4.1 Global Parenteral Drugs Packaging Market Size Overview by Type (2021-2032)
- 1.4.2 Global Parenteral Drugs Packaging Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Parenteral Drugs Packaging Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Parenteral Drugs Packaging Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Parenteral Drugs Packaging Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Parenteral Drugs Packaging Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Parenteral Drugs Packaging Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Parenteral Drugs Packaging Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Parenteral Drugs Packaging Industry Trends
- 2.2 Parenteral Drugs Packaging Industry Drivers
- 2.3 Parenteral Drugs Packaging Industry Opportunities and Challenges
- 2.4 Parenteral Drugs Packaging Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Parenteral Drugs Packaging Revenue (2021-2026)
- 3.2 Global Top Players by Parenteral Drugs Packaging Sales (2021-2026)
- 3.3 Global Top Players by Parenteral Drugs Packaging Price (2021-2026)
- 3.4 Global Parenteral Drugs Packaging Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Parenteral Drugs Packaging Major Company Production Sites & Headquarters
- 3.6 Global Parenteral Drugs Packaging Company, Product Type & Application
- 3.7 Global Parenteral Drugs Packaging Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Parenteral Drugs Packaging Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Parenteral Drugs Packaging Players Market Share by Revenue in 2025
- 3.8.3 2025 Parenteral Drugs Packaging Tier 1, Tier 2, and Tier 3
4 Parenteral Drugs Packaging Regional Status and Outlook
- 4.1 Global Parenteral Drugs Packaging Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Parenteral Drugs Packaging Historic Market Size by Region
- 4.2.1 Global Parenteral Drugs Packaging Sales in Volume by Region (2021-2026)
- 4.2.2 Global Parenteral Drugs Packaging Sales in Value by Region (2021-2026)
- 4.2.3 Global Parenteral Drugs Packaging Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Parenteral Drugs Packaging Forecasted Market Size by Region
- 4.3.1 Global Parenteral Drugs Packaging Sales in Volume by Region (2027-2032)
- 4.3.2 Global Parenteral Drugs Packaging Sales in Value by Region (2027-2032)
- 4.3.3 Global Parenteral Drugs Packaging Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Parenteral Drugs Packaging by Application
- 5.1 Parenteral Drugs Packaging Market by Application
- 5.1.1 Large Volume Parenteral (LVP)
- 5.1.2 Small Volume Parenteral (SVP)
- 5.2 Global Parenteral Drugs Packaging Market Size by Application
- 5.2.1 Global Parenteral Drugs Packaging Market Size Overview by Application (2021-2032)
- 5.2.2 Global Parenteral Drugs Packaging Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Parenteral Drugs Packaging Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Parenteral Drugs Packaging Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Parenteral Drugs Packaging Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Parenteral Drugs Packaging Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Parenteral Drugs Packaging Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Parenteral Drugs Packaging Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Ypsomed Holding AG
- 6.1.1 Ypsomed Holding AG Company Information
- 6.1.2 Ypsomed Holding AG Business Overview
- 6.1.3 Ypsomed Holding AG Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Ypsomed Holding AG Parenteral Drugs Packaging Product Portfolio
- 6.1.5 Ypsomed Holding AG Recent Developments
- 6.2 Gerresheimer AG
- 6.2.1 Gerresheimer AG Company Information
- 6.2.2 Gerresheimer AG Business Overview
- 6.2.3 Gerresheimer AG Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Gerresheimer AG Parenteral Drugs Packaging Product Portfolio
- 6.2.5 Gerresheimer AG Recent Developments
- 6.3 SiO2 Medical Products
- 6.3.1 SiO2 Medical Products Company Information
- 6.3.2 SiO2 Medical Products Business Overview
- 6.3.3 SiO2 Medical Products Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 SiO2 Medical Products Parenteral Drugs Packaging Product Portfolio
- 6.3.5 SiO2 Medical Products Recent Developments
- 6.4 Schott AG
- 6.4.1 Schott AG Company Information
- 6.4.2 Schott AG Business Overview
- 6.4.3 Schott AG Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Schott AG Parenteral Drugs Packaging Product Portfolio
- 6.4.5 Schott AG Recent Developments
- 6.5 Ompi Stevanato Group
- 6.5.1 Ompi Stevanato Group Company Information
- 6.5.2 Ompi Stevanato Group Business Overview
- 6.5.3 Ompi Stevanato Group Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Ompi Stevanato Group Parenteral Drugs Packaging Product Portfolio
- 6.5.5 Ompi Stevanato Group Recent Developments
- 6.6 Becton Dickinson and Company
- 6.6.1 Becton Dickinson and Company Company Information
- 6.6.2 Becton Dickinson and Company Business Overview
- 6.6.3 Becton Dickinson and Company Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Becton Dickinson and Company Parenteral Drugs Packaging Product Portfolio
- 6.6.5 Becton Dickinson and Company Recent Developments
- 6.7 MeadWestvaco Corporation
- 6.7.1 MeadWestvaco Corporation Company Information
- 6.7.2 MeadWestvaco Corporation Business Overview
- 6.7.3 MeadWestvaco Corporation Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 MeadWestvaco Corporation Parenteral Drugs Packaging Product Portfolio
- 6.7.5 MeadWestvaco Corporation Recent Developments
- 6.8 Unilife Corporation Inc
- 6.8.1 Unilife Corporation Inc Company Information
- 6.8.2 Unilife Corporation Inc Business Overview
- 6.8.3 Unilife Corporation Inc Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Unilife Corporation Inc Parenteral Drugs Packaging Product Portfolio
- 6.8.5 Unilife Corporation Inc Recent Developments
- 6.9 West Pharmaceutical Services
- 6.9.1 West Pharmaceutical Services Company Information
- 6.9.2 West Pharmaceutical Services Business Overview
- 6.9.3 West Pharmaceutical Services Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 West Pharmaceutical Services Parenteral Drugs Packaging Product Portfolio
- 6.9.5 West Pharmaceutical Services Recent Developments
- 6.10 Terumo Corporation
- 6.10.1 Terumo Corporation Company Information
- 6.10.2 Terumo Corporation Business Overview
- 6.10.3 Terumo Corporation Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Terumo Corporation Parenteral Drugs Packaging Product Portfolio
- 6.10.5 Terumo Corporation Recent Developments
- 6.11 Berry Plastics Corporation
- 6.11.1 Berry Plastics Corporation Company Information
- 6.11.2 Berry Plastics Corporation Business Overview
- 6.11.3 Berry Plastics Corporation Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Berry Plastics Corporation Parenteral Drugs Packaging Product Portfolio
- 6.11.5 Berry Plastics Corporation Recent Developments
- 6.12 Owens-Illinois
- 6.12.1 Owens-Illinois Company Information
- 6.12.2 Owens-Illinois Business Overview
- 6.12.3 Owens-Illinois Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Owens-Illinois Parenteral Drugs Packaging Product Portfolio
- 6.12.5 Owens-Illinois Recent Developments
- 6.13 RPC Group
- 6.13.1 RPC Group Company Information
- 6.13.2 RPC Group Business Overview
- 6.13.3 RPC Group Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 RPC Group Parenteral Drugs Packaging Product Portfolio
- 6.13.5 RPC Group Recent Developments
- 6.14 Graphic Packaging Group
- 6.14.1 Graphic Packaging Group Company Information
- 6.14.2 Graphic Packaging Group Business Overview
- 6.14.3 Graphic Packaging Group Parenteral Drugs Packaging Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Graphic Packaging Group Parenteral Drugs Packaging Product Portfolio
- 6.14.5 Graphic Packaging Group Recent Developments
7 North America by Country
- 7.1 North America Parenteral Drugs Packaging Sales by Country
- 7.1.1 North America Parenteral Drugs Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Parenteral Drugs Packaging Sales by Country (2021-2026)
- 7.1.3 North America Parenteral Drugs Packaging Sales Forecast by Country (2027-2032)
- 7.2 North America Parenteral Drugs Packaging Market Size by Country
- 7.2.1 North America Parenteral Drugs Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Parenteral Drugs Packaging Market Size by Country (2021-2026)
- 7.2.3 North America Parenteral Drugs Packaging Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Parenteral Drugs Packaging Sales by Country
- 8.1.1 Europe Parenteral Drugs Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Parenteral Drugs Packaging Sales by Country (2021-2026)
- 8.1.3 Europe Parenteral Drugs Packaging Sales Forecast by Country (2027-2032)
- 8.2 Europe Parenteral Drugs Packaging Market Size by Country
- 8.2.1 Europe Parenteral Drugs Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Parenteral Drugs Packaging Market Size by Country (2021-2026)
- 8.2.3 Europe Parenteral Drugs Packaging Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Parenteral Drugs Packaging Sales by Country
- 9.1.1 Asia-Pacific Parenteral Drugs Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Parenteral Drugs Packaging Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Parenteral Drugs Packaging Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Parenteral Drugs Packaging Market Size by Country
- 9.2.1 Asia-Pacific Parenteral Drugs Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Parenteral Drugs Packaging Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Parenteral Drugs Packaging Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Parenteral Drugs Packaging Sales by Country
- 10.1.1 South America Parenteral Drugs Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Parenteral Drugs Packaging Sales by Country (2021-2026)
- 10.1.3 South America Parenteral Drugs Packaging Sales Forecast by Country (2027-2032)
- 10.2 South America Parenteral Drugs Packaging Market Size by Country
- 10.2.1 South America Parenteral Drugs Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Parenteral Drugs Packaging Market Size by Country (2021-2026)
- 10.2.3 South America Parenteral Drugs Packaging Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Parenteral Drugs Packaging Sales by Country
- 11.1.1 Middle East and Africa Parenteral Drugs Packaging Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Parenteral Drugs Packaging Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Parenteral Drugs Packaging Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Parenteral Drugs Packaging Market Size by Country
- 11.2.1 Middle East and Africa Parenteral Drugs Packaging Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Parenteral Drugs Packaging Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Parenteral Drugs Packaging Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Parenteral Drugs Packaging Value Chain Analysis
- 12.1.1 Parenteral Drugs Packaging Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Parenteral Drugs Packaging Production Mode & Process
- 12.2 Parenteral Drugs Packaging Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Parenteral Drugs Packaging Distributors
- 12.2.3 Parenteral Drugs Packaging Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst